Unlock Advanced Pharmaceutical Synthesis with Our Key Intermediate
High-purity chemical building block for Elagolix and complex drug development.
Get a Quote & SampleProduct Core Value
5-Bromo-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methylpyrimidine-2,4(1H,3H)-dione
This high-quality pharmaceutical intermediate is essential for the development of Elagolix, a crucial GnRH antagonist used in treating conditions like endometriosis. Its precise chemical structure and high purity ensure reliable outcomes in complex organic synthesis and drug manufacturing processes.
- Leverage the high purity of our intermediate for Elagolix synthesis, ensuring optimal drug efficacy.
- Utilize CAS 830346-48-0, a critical component in advanced pharmaceutical R&D and chemical synthesis.
- Benefit from the reliable supply of this fluorinated pyrimidine derivative, a key building block for new therapeutic agents.
- Integrate this essential chemical reagent into your laboratory R&D processes for robust and reproducible results.
Advantages
Exceptional Purity
Achieve consistent and successful synthesis outcomes with our >98% pure intermediate for Elagolix synthesis, minimizing side reactions and maximizing yield.
Critical Synthesis Role
As a key building block for GnRH antagonists, this CAS 830346-48-0 pharmaceutical intermediate is vital for developing advanced treatments.
Reliable Supply Chain
Ensure uninterrupted research and production schedules with our stable manufacturing capacity for this important pyrimidine derivative.
Key Applications
Elagolix Manufacturing
This intermediate is a cornerstone in the production of Elagolix, a vital GnRH antagonist, supporting the development of novel therapeutic options.
Drug Discovery Research
Explore new molecular entities and pathways using this advanced chemical reagent in your drug discovery programs.
Organic Synthesis
Employ this complex molecule as a versatile starting material or intermediate in sophisticated organic synthesis projects.
API Intermediates
Essential for the creation of Active Pharmaceutical Ingredients (APIs), facilitating the development of next-generation medicines.